S. Hillier

发表

A paper-based invasion assay: assessing chemotaxis of cancer cells in gradients of oxygen.

G. Whitesides, B. Mosadegh, D. Newsome, 2015, Biomaterials.

Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma.

M. Pomper, K. Gage, L. Dinkelborg, 2010, Cancer research.

A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer.

A. Kozikowski, W. Eckelman, J. Babich, 2009, Journal of medicinal chemistry.

Synthesis and Evaluation of a Series of 99mTc(CO)3+ Lisinopril Complexes for In Vivo Imaging of Angiotensin-Converting Enzyme Expression

V. Dilsizian, W. Eckelman, J. Babich, 2008, Journal of Nuclear Medicine.

Molecular imaging of human ACE-1 expression in transgenic rats.

V. Dilsizian, N. Wong, J. Narula, 2012, JACC. Cardiovascular imaging.

99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer

W. Eckelman, J. Marquis, J. Babich, 2013, The Journal of Nuclear Medicine.

Synthesis and SAR of ⁹⁹mTc/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates.

W. Eckelman, J. Babich, S. Hillier, 2013, Bioorganic & medicinal chemistry letters.

99m Tc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer

W. Eckelman, J. Marquis, J. Babich, 2013 .

99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer

W. Eckelman, J. Marquis, J. Babich, 2013, The Journal of Nuclear Medicine.

Disruption of gene expression and induction of apoptosis in prostate cancer cells by a DNA-damaging agent tethered to an androgen receptor ligand.

J. Essigmann, J. Marquis, S. Hillier, 2005, Chemistry & biology.

Synthesis and SAR of novel Re/99mTc-labeled benzenesulfonamide carbonic anhydrase IX inhibitors for molecular imaging of tumor hypoxia.

W. Eckelman, J. Babich, S. Hillier, 2013, Journal of medicinal chemistry.

Small molecule inhibitors of PSMA incorporating technetium-99m for imaging prostate cancer: Effects of chelate design on pharmacokinetics

W. Eckelman, J. Marquis, J. Babich, 2012 .

Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution.

J. Babich, S. Hillier, K. Maresca, 2010, Cancer biotherapy & radiopharmaceuticals.

Semisynthetic hydrophilic polyals.

A. Fischman, M. Papisov, S. Hillier, 2005, Biomacromolecules.

[131I]MIP-1466, a small molecule prostate-specific membrane antigen (PSMA) inhibitor for targeted radiotherapy of prostate cancer (PCa)

W. Eckelman, J. Marquis, J. Babich, 2012 .

on Efficacy, Pharmacokinetics, and Tissue Distribution

J. Babich, S. Hillier, K. Maresca, 2018 .

Use of RNAi to Investigate Eµ-myc Lymphomagenesis and Lymphoma Chemoresistance

M. Hemann, J. Essigmann, B. Zayas, 2004 .

Preparation and pharmacokinetics of 11C labeled stavudine (d4T).

A. Fischman, R. Rubin, E. Livni, 2004, Nuclear medicine and biology.

Triazole Appending Agent (TAAG): A New Synthon for Preparing Iodine-Based Molecular Imaging and Radiotherapy Agents.

J. Valliant, J. Babich, S. Hillier, 2012, ACS medicinal chemistry letters.

Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.

W. Eckelman, J. Marquis, J. Babich, 2010, Bioconjugate chemistry.

Metabolic response of lung cancer cells to radiation in a paper-based 3D cell culture system.

George M Whitesides, Bobak Mosadegh, Kyaw Thu Minn, 2016, Biomaterials.

Phase-1 Clinical Trial Results of High-Specific-Activity Carrier-Free 123I-Iobenguane

N. Petry, J. Babich, M. Stabin, 2014, The Journal of Nuclear Medicine.

Phase-1 Clinical Trial Results of High-Specific-Activity Carrier-Free 123 I-Iobenguane

N. Petry, J. Babich, M. Stabin, 2014 .

Synthesis and structural characterization of the neutral indium (III) thiolate species In{(SCH2CH2)3N}

A. Fischman, J. Zubieta, J. Babich, 1998 .

Synthesis, Cytotoxicity, and Insight into the Mode of Action of Re(CO)3 Thymidine Complexes

J. Zubieta, M. Bartholomä, B. Ploier, 2010, ChemMedChem.

Synthesis, cytotoxicity and cellular uptake studies of N3 functionalized Re(CO)3 thymidine complexes.

J. Zubieta, M. Bartholomä, J. Babich, 2011, Dalton transactions.

A rationally designed genotoxin that selectively destroys estrogen receptor-positive breast cancer cells.

J. Essigmann, B. Zayas, J. Marquis, 2002, Journal of the American Chemical Society.

123I-MIP-1072, a Small-Molecule Inhibitor of Prostate-Specific Membrane Antigen, Is Effective at Monitoring Tumor Response to Taxane Therapy

W. Eckelman, J. Marquis, J. Babich, 2011, The Journal of Nuclear Medicine.

DNA adducts formed by a novel antitumor agent 11β-dichloro in vitro and in vivo

Steven R Tannenbaum, S. Tannenbaum, J. Essigmann, 2006, Molecular Cancer Therapeutics.

Chemical Genetics Analysis of an Aniline Mustard Anticancer Agent Reveals Complex I of the Electron Transport Chain as a Target*

J. Essigmann, S. Hillier, Angela Zhu, 2011, The Journal of Biological Chemistry.

Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer.

Martin G Pomper, William C Eckelman, John W Babich, 2009, Cancer research.

Design, synthesis, and evaluation of estradiol-linked genotoxicants as anti-cancer agents.

J. Essigmann, J. Marquis, S. Hillier, 2004, Bioorganic & medicinal chemistry letters.

Synthetic mRNA rescues very long-chain acyl-CoA dehydrogenase deficiency in patient fibroblasts and a murine model.

P. Giangrande, L. Rice, J. Vockley, 2022, Molecular genetics and metabolism.

Tc-99m labeled small-molecule inhibitors of prostate-specific membrane antigen (PSMA): New molecular imaging probes to detect metastatic prostate adenocarcinoma (PC).

S. Vallabhajosula, J. Osborne, S. Tagawa, 2012, Journal of Clinical Oncology.

Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.

W. Eckelman, J. Marquis, J. Babich, 2010, Bioconjugate chemistry.

Metabolic response of lung cancer cells to radiation in a paper-based 3D cell culture system.

G. Whitesides, B. Mosadegh, T. Udagawa, 2016, Biomaterials.

Comprehensive radiolabeling, stability, and tissue distribution studies of technetium-99m single amino acid chelates (SAAC).

J. Zubieta, J. Valliant, S. Banerjee, 2009, Bioconjugate chemistry.

Synthesis and Evaluation of a Series of 99mTc(CO)3+ Lisinopril Complexes for In Vivo Imaging of Angiotensin-Converting Enzyme Expression

V. Dilsizian, W. Eckelman, J. Babich, 2008, Journal of Nuclear Medicine.